Komodo Drug Projections
Finally, a Projection Built on the Whole Market
Specialty pharmacy, medical benefit, mail order. Most tools miss where prescriptions actually live today. Komodo doesn’t. Weekly. Down to the prescriber.
The Problem with the Status Quo Black-Box Projections Are a Liability
When specialty pharmacy blocks data and your model can’t account for it, you don’t know if you’re seeing a market shift or a methodology failure. That’s not a projection. It’s a guess.
Built for How the Market Actually Works
Most projection tools were built for a retail-first world. Mail order, specialty pharmacy, and medical benefit channels now represent a significant and growing share of the market. Projections that don’t account for all of them don’t reflect reality. Komodo was built on payer- and provider-complete data, so your projections don’t have blind spots.
Observed and Projected
See both the projected value and the real-world observed data. Know when to trust the number and when to question it.
Down to the Prescriber
Projections at the HCP, HCO, and ZIP level. Weekly. Your field team acts on it before competitors see the trend.
Confidence Intervals Built In
Not an estimate with no context. A range, with methodology you can stand behind in front of leadership and investors.
What You Can Do With It
When your projections account for every channel, the use cases change. Not just what happened in retail. What’s actually happening across the whole market, in your territory, this week.
Market Share Tracking
Track your product vs. competitors at the account, provider, and rep level. Updated weekly to see real-time shifts.
Launch Modeling
Build launch curves and model new drug uptake. Our whole market view captures hard-to-project products.
Field and Territory Strategy
Segment HCPs by treatment rate, identify early adopters, and design territories based on actual data.
“[Komodo Drug Projections] presented a trend line that showed growth in an area that we weren’t expecting and we had not seen yet. And some of our other benchmarks and data partners didn’t have that timely data yet. So it really jumped off the page in terms of what [Projections] is able to do.”
Senior Director, Data Strategy and Innovation Global Oncology · Merck
Go Deeper on Drug Projections
Finally, Projected Data You Can Trust
Most projected data falls short on accuracy. Learn how Komodo built national drug projections you can stake decisions on.
Behind the Forecast: Drug Projections
Get a front-row seat to how Komodo builds national drug projections. See the methodology, the data, and the use cases that matter to your team.
The Edge Your Investment Strategy Needs
See how commercial and investment teams use Komodo drug projections to spot market shifts before they happen.
Your Projections Should Tell You Something Your Competitors Can’t See
Komodo Drug Projections is built on payer- and provider-complete data, with transparent methodology and subnational detail that goes down to the prescriber. If your current solution can’t show you observed vs. projected, it’s time to compare.